Stock screenerAll disclosures →
EDGAR →
NTLA
Conviction 24HealthcareScan · Mon, Aug 10, 2026NTLA$12.02+0.67%
ResistanceSupportVol 14Vol MA14 3.78M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price12.02
Change+0.67%
Gap-0.59%
Rel volume1.10×
Avg volume3.95M
Avg $ vol45.18M
SMA 2011.37
SMA 5013.51
SMA 20012.65
Price vs 50-11.00%
Price vs 200-4.98%
MA stackmixed
50/200 cross—
Supertrenddown · 12.83
RSI (14)48
MACD hist0.21
MACD crossbull · 3d
Stoch %K / %D89 / 85
ADX (14)32
+DI / −DI21 / 26
RSI divergence—
MACD divergence—
ATR %+6.36%
ADR %5.15%
52w high27.98
52w low8.04
From 52w high-57.04%
Above 52w low+49.50%
New 52w highNo
SqueezeOff
Bollinger width25.37%
%B0.73
Donchian pos54.68%
Donchian high13.57
Donchian low10.15
AVWAP (52w high)13.02
vs AVWAP high-7.69%
AVWAP (52w low)12.90
vs AVWAP low-6.80%
OBV trendFlat
Chaikin MF (20)-0.05
Today vs 20d1.10×
Avg vol (14d)3.78M
Avg vol (20d)3.95M
Avg $ vol (20d)45.18M
Market cap1.68B
RS 3m (vs SPY)-18.61%
RS 6m (vs SPY)-6.45%
RS line new highNo
Trend template3/8
Technical rank26.9
1 week+11.61%
1 month-15.44%
3 months-14.69%
6 months-2.12%
1 year+4.89%
YTD+30.51%
P/E-4.08
P/B2.31
P/S24.89
P/FCF-4.25
EPS-3.81
Div yield—
ROE-56.71%
ROA-48.15%
Debt/Eq—
Current6.65
EV/EBITDA-3.66
Gross margin—
Net margin-609.85%
Rev growth16.92%
EPS growth20.49%
Price target19.15
Target upside59.32%
Analyst ratingBuy
Institutional95.03%
Ent. value1.58B
Revenue7.66M
Net income-106.63M
Gross profit—
Free cash flow-395.87M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out139.72M
Employees377
ListedFri, May 6, 2016
Free float96.07M
Float %82.9%
Short interest45.78M
Days to cover9.8d
Short volume55.7%
Squeeze score77 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.80 vs −$0.80
Last surprise0.0% beat
Setup gradeD
Conviction24 / 100
Pattern quality—
Tech rank26.9 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance17.61
Support10.28
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NTLA
No recent disclosed trades by Congress in NTLA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NTLA · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Cohen Fred E Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
Verwiel Frank Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
Bhanji Muna Director · Stock Option (right to buy) · 2026-06-09 | Grant | 13.3K | $0 | 2026-06-09 | 2026-06-10 |
Keresty Georgia Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
Keresty Georgia Director · Stock Option (right to buy) · 2026-06-09 | Grant | 13.3K | $0 | 2026-06-09 | 2026-06-10 |
GOODMAN JESSE Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
GOODMAN JESSE Director · Stock Option (right to buy) · 2026-06-09 | Grant | 13.3K | $0 | 2026-06-09 | 2026-06-10 |
CHASE WILLIAM J Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
Verwiel Frank Director · Stock Option (right to buy) · 2026-06-09 | Grant | 13.3K | $0 | 2026-06-09 | 2026-06-10 |
Goff Brian Director · Common Stock · 2026-06-09 | Grant | 9.2K | $0 | 2026-06-09 | 2026-06-10 |
SEC filings
EDGAR filings in NTLA · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.